*  Etoposide Injection by Fresenius - Uses, Side Effects, Interactions - Canada.com
Etoposide belongs to the group of cancer-fighting medications called antineoplastics. Etoposide kills cancer cells by ... Etoposide is used alone or in combination with other antineoplastic medications to treat many types of cancer. These include ... Etoposide capsules should be taken on an empty stomach. Etoposide often causes nausea and vomiting, but it is very important ... Etoposide belongs to the group of cancer-fighting medications called antineoplastics. Etoposide kills cancer cells by ...
  http://bodyandhealth.canada.com/drug/getdrug/etoposide-injection-by-fresenius
*  VP-16 - Drugs.com
Etoposide is reported as an ingredient of VP-16 in the following countries:. *Chile ...
  https://www.drugs.com/international/vp-16.html
*  Oxaliplatin, Ifosfamide and Etoposide in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma - Full...
Drug Information available for: Ifosfamide Etoposide Oxaliplatin Etoposide phosphate Genetic and Rare Diseases Information ... Oxaliplatin, Ifosfamide and Etoposide in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma. This ... Patients receive oxaliplatin IV over 2 hours on day 1 and etoposide IV over 1 hour on days 1-3. Courses repeat every 21 days in ... Patients receive oxaliplatin IV over 2 hours on day 1 and etoposide IV over 1 hour on days 1-3. Courses repeat every 21 days in ...
  https://clinicaltrials.gov/ct2/show/NCT00101205
*  Abstract B81: Phase I/II trial of vorinostat in combination with etoposide in pediatric patients with relapsed/refractory solid...
Etoposide was administered at a fixed dose of 100 mg/m2/day on days 3-5 of the treatment cycle. Etoposide was administered 4 ... The recommended phase II dose was established at vorinostat 270 mg/m2 and etoposide 100 mg/m2 and will be evaluated in an ... One patient experienced a DLT (Gr 4 platelet count decreased) at the 1stdose level (125 mg/m2 vorinostat,100 mg/m2 etoposide). ... A multi-center, open label phase I study with escalating doses of vorinostat in combination with etoposide was conducted to ...
  http://mct.aacrjournals.org/content/12/11_Supplement/B81
*  Glentham Life Sciences | Product Search: Etoposide
Search results for Etoposide at Glentham Life Sciences. Find catalogue prices, chemical data, technical specifications and MSDS ...
  https://www.glentham.com/en/products/search/?q=Etoposide
*  Superiority of sequential versus concurrent administration of paclitaxel with etoposide in advanced non-small cell lung cancer:...
All patients received etoposide at 100 mg/m2, given as an i.v. infusion on days 1, 2, and 3. The first 20 patients (part A) ... Paclitaxel and etoposide are two chemotherapy agents with broad cytotoxic activity and different mechanisms of action and ... Our findings suggest that etoposide followed by paclitaxel is well tolerated and has greater activity in NSCLC than concurrent ... We performed two sequential Phase II trials using different sequence schedules of paclitaxel and etoposide as first-line ...
  http://clincancerres.aacrjournals.org/content/4/11/2723
*  Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients | 21 Years at Diagnosis With Refractory Solid...
... vorinostat and etoposide, is in treating cancer. The medication etoposide is a standard medication used in the treatment of ... Experimental: Vorinostat and Etoposide This is a multi-center, open label, phase I/II trial of escalating doses of vorinostat ... Drug: Vorinostat and Etoposide Patients will be assessed in 3-week cycles. Escalating doses of vorinostat will be administered ... Etoposide will be administered intravenously daily x 3 days. Cohorts of 3-6 patients will be treated with vorinostat and ...
  https://clinicaltrials.gov/ct2/show/record/NCT01294670
*  Etoposide Pharmaswiss - Drugs.com
A list of US medications equivalent to Etoposide Pharmaswiss is available on the Drugs.com website. ... Etoposide Pharmaswiss is a medicine available in a number of countries worldwide. ... Ingredient matches for Etoposide Pharmaswiss. Etoposide. Etoposide is reported as an ingredient of Etoposide Pharmaswiss in the ... Etoposide Pharmaswiss. Etoposide Pharmaswiss may be available in the countries listed below. ...
  https://www.drugs.com/international/etoposide-pharmaswiss.html
*  Carboplatin & etoposide - Information and support - Macmillan Cancer Support
If you or someone close to you has been diagnosed with cancer, you're not alone. Find out what to expect, get information, practical advice and support, hear from experts and read about other people's experiences.
  https://www.macmillan.org.uk/information-and-support/lung-cancer/small-cell-lung-cancer/treating/chemotherapy/drugs-and-combination-regimens/combination-chemotherapy/carboplatin-and-etoposide.html
*  Etoposide Capsule - FDA prescribing information, side effects and uses
Etoposide Capsule official prescribing information for healthcare professionals. Includes: indications, dosage, adverse ... Etoposide Capsule Dosage and Administration. Etoposide Capsules. In small cell lung cancer, the recommended dose of Etoposide ... How is Etoposide Capsule Supplied. Etoposide Capsules, USP are available containing 50 mg of etoposide, USP. ... increase in etoposide exposure with a 38% decrease in total body clearance of etoposide compared to etoposide alone. ...
  https://www.drugs.com/pro/etoposide-capsule.html
*  Brevet US6713454 - Prodrugs of etoposide and etoposide analogs - Google Brevets
An etoposide prodrug comprising an etoposide coupled at each of the three hydroxy bonding sites of the etoposide to an oligomer ... An etoposide prodrug comprising an etoposide coupled at each of the three hydroxy bonding sites of the etoposide to an oligomer ... An etoposide prodrug comprising an etoposide coupled at each of the three hydroxy bonding sites of the etoposide to an oligomer ... An etoposide prodrug comprising:. (a) an etoposide therapeutic compound selected from the group consisting of etoposide and an ...
  http://www.google.fr/patents/US6713454
*  Etoposide Injection by Fresenius - Pharmasave
Etoposide capsules should be taken on an empty stomach. Etoposide often causes nausea and vomiting, but it is very important ... Etoposide belongs to the group of cancer-fighting medications called antineoplastics. Etoposide kills cancer cells by ... Etoposide can cause changes to sperm in men, decreasing fertility. Women and men receiving etoposide should use effective ... Etoposide is used alone or in combination with other antineoplastic medications to treat many types of cancer. These include ...
  http://www.pharmasave.com/medications/etoposide-injection-by-fresenius/
*  Etoposide (By mouth) | Lima Memorial Health System
Etoposide (By mouth). Etoposide (e-TOE-poe-side). Treats testicle cancer, lung cancer, lymphomas, nonlymphocytic leukemia, and ... Etoposide is sometimes given together with certain other medicines. If you are using a combination of medicines, make sure that ... You should not use this medicine if you have had an allergic reaction to etoposide.. How to Use This Medicine: Capsule, Liquid ...
  http://www.limamemorial.org/health-library/Thomson%20DrugNotes/45/0736
*  Bleomycin/cisplatin/etoposide | Springer for Research & Development
Bernard P, Cellarier G, Crémades S, Gisserot O, De Jauréguiberry J-P.Early myocardial infarction associated with chemotherapy for testicular cancer. Revue de Medecine Interne 27: 497-498, No. 6, Jun 2006 - FranceGoogle Scholar ...
  https://rd.springer.com/article/10.2165/00128415-200611200-00019
*  Etoposide in Treating Young Patients With Relapsed Ependymoma - Full Text View - ClinicalTrials.gov
Drug Information available for: Etoposide Etoposide phosphate Genetic and Rare Diseases Information Center resources: ... Etoposide. Etoposide phosphate. Antineoplastic Agents, Phytogenic. Antineoplastic Agents. Topoisomerase II Inhibitors. ... Etoposide in Treating Young Patients With Relapsed Ependymoma. The safety and scientific validity of this study is the ... Patients receive etoposide IV over 1 hour on days 1-3, 8-10, and 15-17. Treatment repeats every 28 days for up to 6 courses in ...
  https://clinicaltrials.gov/ct2/show/NCT00278252
*  Human Metabolome Database: Showing metabocard for Etoposide (HMDB0014911)
Etoposide. Description. A semisynthetic derivative of podophyllotoxin that exhibits antitumor activity. Etoposide inhibits DNA ... mediates etoposide resistance and transport, but etoposide oral availability is limited primarily by P-glycoprotein. Cancer Res ... The enzyme also hydroxylates etoposide. Gene Name:. CYP3A4. Uniprot ID:. P08684 Molecular weight:. 57255.585. References. * ... Showing metabocard for Etoposide (HMDB0014911). IdentificationTaxonomyOntologyPhysical propertiesSpectraBiological properties ...
  http://www.hmdb.ca/metabolites/HMDB14911
*  Protracted Etoposide During Induction Therapy for High Risk Neuroblastoma - Tabular View - ClinicalTrials.gov
Protracted Etoposide During Induction Therapy for High Risk Neuroblastoma. Official Title ICMJE PEPI: Protracted Etoposide in a ... Cisplatin and etoposide: Cisplatin will be given once a day for 5 days through an IV. Etoposide will be given either by mouth ... Experimental: Protracted Oral Etoposide Protracted etoposide for cycles 1, 2 and 4 of induction. If a subject does not respond ... Drug: Protracted Oral Etoposide IV Cisplatin and Oral Protracted Etoposide for induction ...
  https://clinicaltrials.gov/ct2/show/record/NCT00578864
*  Etoposide, Doxorubicin, Vincristine, Cyclophosphamide, Prednisone (EPOCH) for Treatment of Lymphomas
A Phase II Study to Evaluate the Efficacy of Ramosetron, Aprepitant, and Dexamethasone in Preventing Cisplatin-Induced Nausea and Vomiting in Chemotherapy-Naïve Cancer Patients. Geundoo Jang; Hun Ho Song; Keon Uk Park; Hyeong Su Kim; Dae Ro Choi; Jung Hye Kwon; Ho Young Kim; Boram Han; Jung Han Kim; Joo Young Jung; Hyo Jung Kim; Dae Young Zang // Cancer Research & Treatment;Sep2013, Vol. 45 Issue 3, p172 Purpose: Combination therapy with aprepitant, serotonin receptor antagonist, and steroids improves the complete response rate of both acute and delayed chemotherapyinduced nausea and vomiting (CINV). However, it is not known whether ramosetron is suitable for administration in combination with... ...
  http://connection.ebscohost.com/c/articles/27587061/etoposide-doxorubicin-vincristine-cyclophosphamide-prednisone-epoch-treatment-lymphomas
*  Reduction of atherosclerotic lesions in rabbits treated with etoposide | IJN
In previous studies, treatment of refractory cancer patients with etoposide associated with LDE had been shown devoid of ... In this study, the ability of etoposide to reduce lesions and inflammatory factors in atherosclerotic rabbits was investigated. ... Starting from day 30, nine animals were treated with four weekly intravenous injections of etoposide oleate (6 mg/kg) ... The ability of LDE-etoposide to strongly reduce the lesion area and the inflammatory process warrants the great therapeutic ...
  https://www.dovepress.com/reduction-of-atherosclerotic-lesions-in-rabbits-treated-with-etoposide-peer-reviewed-article-IJN
*  Neuroectodermal Tumors Completed Phase 1 Trials for DB00773 (Etoposide) - DrugBank
Valproate and Etoposide for Patients With Neuronal Tumors and Brain Metastases. Treatment. *DB00773 (Etoposide) ... Neuroectodermal Tumors Completed Phase 1 Trials for DB00773 (Etoposide). Back to Neuroectodermal Tumors ...
  https://www.drugbank.ca/indications/DBCOND0040519/clinical_trials/DB00773?phase=1&status=completed
*  Etoposide, cyclophosphamide, cisplatin, and doxorubicin as neoadjuvant chemotherapy for osteosarcoma
... Cassano WF, Graham-Pole J ... The authors evaluated the combination of etoposide/cyclophosphamide (VP/CY) as initial, presurgical therapy for patients with ... After definitive, limb-salvage surgery and adjuvant chemotherapy with etoposide, cyclophosphamide, cisplatin, and doxorubicin, ...
  https://imsdd.meb.uni-bonn.de/cgi-bin/mycite?ExtRef=MEDL/92005294/PMID/1913541
*  Etoposide, Oxaliplatin and Capecitabine in Advanced Hepatocellular Carcinoma (HCC) - Full Text View - ClinicalTrials.gov
Etoposide phosphate. Etoposide. Antimetabolites, Antineoplastic. Antimetabolites. Molecular Mechanisms of Pharmacological ... Etoposide, Oxaliplatin and Capecitabine in Advanced Hepatocellular Carcinoma (HCC). The safety and scientific validity of this ... The three agents etoposide, oxaliplatin and capecitabine each has sparse efficacy as single agents, but the combination may act ... Etoposide are administered intravenously 100 mg/m2 on day 1 and orally 200 mg/m2 on days 2 and 3. ...
  https://clinicaltrials.gov/ct2/show/NCT00351195
*  Carfilzomib in Combination With Cyclophosphamide and Etoposide for Children - Full Text View - ClinicalTrials.gov
Etoposide phosphate. Etoposide. Immunosuppressive Agents. Immunologic Factors. Physiological Effects of Drugs. Antirheumatic ... Carfilzomib in Combination With Cyclophosphamide and Etoposide for Children (POE14-01). The safety and scientific validity of ... The medications cyclophosphamide and etoposide are standard drugs often used together for the treatment of cancer in children ... To determine the DLTs and MTD of carfilzomib given in combination with cyclophosphamide and etoposide in pediatric patients ...
  https://clinicaltrials.gov/ct2/show/NCT02512926